Home › Bronchiolitis Obliterans Syndrome › Missouri
Bronchiolitis Obliterans Syndrome clinical trials in Missouri
4 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in Missouri.
Cities in Missouri
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
- Ophthalmology Associates, St Louis
RecruitingPhase 3
Ages 10 to 65 · All sexes · Updated Sep 21, 2026 · NCT07395232A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Washington University School of Medicine, St Louis
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Washington University, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06615050A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Washington University School of Medicine - Siteman Cancer Center, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.